Related MeSH Hierarchy (6)
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma » Carcinoma, Islet Cell » Glucagonoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Pancreatic Neoplasms » Carcinoma, Islet Cell » Glucagonoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Pancreatic Neoplasms » Carcinoma, Islet Cell » Glucagonoma
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Pancreatic Neoplasms » Carcinoma, Islet Cell » Glucagonoma
Diseases [C] » Digestive System Diseases [C06] » Pancreatic Diseases » Pancreatic Neoplasms » Carcinoma, Islet Cell » Glucagonoma
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Pancreatic Neoplasms » Carcinoma, Islet Cell » Glucagonoma
Description
An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA. MeSH
Hierarchy View
Phase 1 Indicated Drugs (5)
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.